To check possible outbreak of the Ebola Virus Disease in
Enugu State, the Minister of Information, Labaran Maku, on Wednesday disclosed
that 20 persons have been quarantined in the state.
Briefing State House correspondents at the end of the
Federal Executive Council meeting presided over by President Goodluck Jonathan,
said 198 persons are currently under watch by the Ministry of Health to contain
further spread of the disease.
A nurse had earlier fled the Lagos quarantine centre and
travelled to Enugu where she had contact with 20 other people.
Of the 198 persons under surveillance, he said that 177 of
them are in Lagos, while 21 are in Enugu.
He said:
Out of this number, 177 are in Lagos and
are being traced. Some are in quarantine, some are being monitored by health
specialists.”
“21 persons in Enugu are also being watched. This is because
one of the nurses that was involved with the treatment of the index case,
unfortunately, disobeyed medical instructions and somehow travelled to Enugu.”
“All those who she was in contact with including her husband
are under quarantine. The medical team had been able to trace all those who
made contact with her.”
He urged members of the public to discountenance rumours and
unverified reports over the Ebola epidemic, saying the government will
prosecute anybody spreading rumors that damage public health.
He said: “Health workers are now in all our border units.
All the entry points into this country and exit points, we have port health
workers that are working in our airports and seaports.”
Meanwhile The National Health Research Ethics Committee of
Nigeria has approved the use of an experimental Ebola drug, Zmapp, for
treatment of patients infected with the virus.
The committee, which comprises
research scientists, is a national body under the Federal Ministry of Health.
The endorsement is contained in a statement made available to journalists and
signed by Dr. Clement Adebamowo, chairman of the committee.
“It is ethical to
use these treatments in the current situation without first submitting an
application to National, State or Institutional Health Research Ethics
Committee for prior review and approval. In addition, the committee waives the
current requirement that international shipment of any biological samples out
of Nigeria should be preceded by the establishment of a Materials Transfer
Agreement. This waiver is to promote rapid international response to this
global emergency,” the statement said.
In the statement, the Nigerian National Code for Health
Research Ethics emphasised that all innovative and non-validated treatments
should be carefully and adequately documented.
It said the documentation can
form the basis for clinical trials of the efficacy and side effects of the
treatment according to established scientific principles. It added that the
ethics committee enjoins all agencies, development partners and research
scientists to follow the guidelines for rapid resolution of the current
emergency.
“The guideline will contribute to preparedness in case of
future occurrences and contribution to scientific knowledge. It must be noted
that all Phase O and Phase I Clinical Trials that may subsequently be designed
for treatment of this infection can be approved only by the National Health
Research Ethics Committee,” it said.
The decision by the committee is coming on
the heels of Tuesday’s approval by the World Health Organisation, WHO, on the
use of experimental drug, ZMapp, for treatment of Ebola patients.
No comments:
Post a Comment